IPP Bureau
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
By IPP Bureau - March 09, 2023
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
Evonik opens new facility for pharmaceutical lipids in Germany
By IPP Bureau - March 09, 2023
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Alembic receives USFDA final approval for Prazosin Hydrochloride Capsules
By IPP Bureau - March 09, 2023
Prazosin Hydrochloride Capsule is indicated for the treatment of hypertension, to lower blood pressure
Eugia Pharma receives USFDA approval for Lenalidomide Capsules
By IPP Bureau - March 09, 2023
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Caplin Steriles gets USFDA approval for Thiamine Hydrochloride Injection
By IPP Bureau - March 09, 2023
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Jubilant Pharmova receives VAI from USFDA for its API manufacturing facility
By IPP Bureau - March 09, 2023
Based on this inspection and the USFDA VAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP)
Lonza upgrades powder characterization capabilities at Tampa
By IPP Bureau - March 09, 2023
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Polson Tie-up buys 10.01% stake in Natural Biogenex
By IPP Bureau - March 08, 2023
Natural Capsules Limited's shareholding will be reduced to 89.99%
93% companies lack the culture and organizational structure to unlock digital growth: Infosys
By IPP Bureau - March 08, 2023
Digital success is contingent on the way a company organizes itself around technology
Sun Pharma completes acquisition of Concert Pharmaceuticals
By IPP Bureau - March 07, 2023
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
Alembic Pharmaceuticals gets USFDA final approval for fluorouracil injection
By IPP Bureau - March 07, 2023
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
Venus Remedies joins India AMR Innovation Hub
By IPP Bureau - March 07, 2023
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
USFDA approves intramuscular administration for Merck’s MMRV family of vaccines
By IPP Bureau - March 07, 2023
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
Apollo partners with LifeSigns to donate 1000 remote patient monitoring patches to Turkey
By IPP Bureau - March 07, 2023
These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
Evonik partners with AMSilk to manufacture sustainable silk proteins
By IPP Bureau - March 07, 2023
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
